Assignee profile:

Vironovative B.V.

City:

Rotterdam

Country:

Netherlands

Published Applications:

9

Last publication date:

2019-04-25

Patent Grants:

7

Last grant date:

2019-12-31

Top Inventors for applications by Vironovative B.V.

These are the the leading inventors for applications assigned to Vironovative B.V.:

Recent patent applications by Vironovative B.V.

Vironovative B.V. based in Rotterdam, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-04-25 ✅ Patent 10,519,517 granted on 2019-12-31
US20190119762A1
Chemistry; metallurgy

Virus causing respiratory tract illness in susceptible mammals

#2 | 2010-11-04
US20100278813A1
Chemistry; metallurgy

Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies

#3 | 2010-06-10 ✅ Patent 8,722,341 granted on 2014-05-13
US20100143407A1
Chemistry; metallurgy

Metapneumovirus strains and their use in vaccine formulations and sequences

#4 | 2009-10-01 ✅ Patent 8,841,433 granted on 2014-09-23
US20090246855A1
Chemistry; metallurgy

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

#5 | 2009-05-12 ✅ Patent 7,531,342 granted on 2009-05-12
US10371122
-

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

#6 | 2008-11-11 ✅ Patent 7,449,324 granted on 2008-11-11
US10371099
-

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

#7 | 2007-06-14
US20070134255A1
Human necessities

Hmpv treatment with ribavirin and anti-hmpv antibody

#8 | 2005-06-02 ✅ Patent 8,927,206 granted on 2015-01-06
US20050118195A1
Chemistry; metallurgy

Virus causing respiratory tract illness in susceptible mammals

#9 | 2005-01-27 ✅ Patent 7,704,720 granted on 2010-04-27
US20050019891A1
Chemistry; metallurgy

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus

AssigneeID:

226228 ⎘